Fingerpaint Group appointed Sarah Cherng as its new Chief Technology & Product Officer to strengthen AI innovation and technology leadership. The Chief Technology & Product Officer role will support enterprise data science, healthcare technology, and machine learning efforts. Moreover, Cherng will report directly to CEO Bill McEllen. Fingerpaint Group also aims to expand its human-led, AI-enabled approach through this appointment.
Cherng brings more than 20 years of experience in enterprise data science and AI leadership. Most recently, she served as Chief Artificial Intelligence Officer at Aura. There, she led engineering and AI teams during a successful liquidity event. Additionally, she built a centralized platform that combined machine learning, large language models, and agentic frameworks into customer-facing products.
Previously, Cherng delivered more than $200 million in business value at The Estée Lauder Companies. She also led the Data Science and Advanced Analytics team to support global brands and functions. Furthermore, she guided analytics transformation efforts and broader technology restructuring.
At Merck, Cherng directed Global Oncology Data and Analytics for a major oncology portfolio. Earlier, she led machine learning engineers and quantitative scientists at Flatiron Health to support cancer endpoint research.
“She translates complex data science and AI into tangible business value and has a proven track record of scaling high-performing organizations,” said Bill McEllen, CEO of Fingerpaint Group. “Sarah is exactly the leader to help us push our work further.”
In her new role, Cherng will shape technology strategy, modernize data infrastructure, and guide clients through AI complexity.
“Data in the life sciences industry has been historically siloed. While traditional models have been around for years, the introduction and steady improvement of productized LLMs finally gives us the power to unify that data and enable accessibility that can unlock deeper contextual insights to benefit patients. To scale this responsibly, you need an organization with deep scientific integrity and established client trust. Fingerpaint checks those boxes, and the opportunity to build a unified and compounding commercialization platform here is particularly unique and a core reason for why I chose to join them,” said Cherng.
For more stories on technology leaders shaping the future of enterprise solutions, visit our CXO Insiders.
Source: PRNewswire
